fluorodeoxyglucose f18 has been researched along with Depressive Disorder, Major in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (5.00) | 18.2507 |
2000's | 33 (55.00) | 29.6817 |
2010's | 19 (31.67) | 24.3611 |
2020's | 5 (8.33) | 2.80 |
Authors | Studies |
---|---|
Can, B; Durmuş, NŞ; Tufan, A | 1 |
Baeken, C; Wu, GR | 2 |
Cao, XY; Guo, XW; Hu, XS; Liao, JW; Ma, P; Pan, JY; Wen, JF | 1 |
Baghal, A; Eichhorn, J; Haq, I; Wang, X | 1 |
Kondo, S; Momose, T; Okamura, T; Takahashi, M; Yokoyama, T | 1 |
Abe, K; Chiba, Y; Hirayasu, Y; Ihata, A; Ikura, T; Kamada, A; Katsuse, O; Kirino, Y; Minegishi, K; Ogawa, M; Saito, T; Suda, A; Tamura, M; Yoshimi, R | 1 |
Baeken, C; De Raedt, R; Van Schuerbeek, P; Wu, GR | 1 |
Lajoie, C; Levasseur, MA; Paquet, N | 1 |
Drevets, WC; Hasler, G; Homan, P | 1 |
Galfalvy, HC; Malone, KM; Mann, JJ; Milak, MS; Oquendo, MA; Sublette, ME | 1 |
Anderson, SA; Bannon, M; Fagergren, P; Hurd, YL; Keller, E; Michaelides, M; Neumaier, JF; Ren, Y; Thanos, PK; Volkow, ND; Wang, GJ; Zarnegar, P | 1 |
Craighead, WE; Dunlop, BW; Holtzheimer, PE; Kelley, ME; Mayberg, HS; McGrath, CL | 1 |
Benson, BE; George, MS; Herscovitch, P; Ketter, TA; Kimbrell, TA; Post, RM; Speer, A; Willis, MW | 1 |
Bramon, E; Cai, Y; Dutt, A; Shi, S; Su, L; Xu, Y | 1 |
Beer, AJ; Riepe, MW; Vonend, C; Walther, B | 1 |
Fu, C; Gao, Y; Shi, D; Xu, J; Zhang, H | 1 |
Chen, MH; Hong, CJ; Li, CT; Lin, WC; Liu, RS; Su, TP; Tu, PC; Yang, BH | 1 |
Cao, YX; Dong, JC; Du, YJ; Ge, JJ; Guan, YH; Liu, BJ; Wei, K; Xue, HL; Zhang, HY; Zuo, CT | 1 |
Kim, IJ; Kim, SJ; Kim, YK; Kwak, IS; Song, SH | 1 |
Benson, BE; Herscovitch, P; Kimbrell, TK; Post, RM; Speer, AM; Wassermann, EM; Willis, MW | 1 |
Freed, PJ; Hibbeln, JR; Malone, KM; Mann, JJ; Milak, MS; Oquendo, MA; Parsey, RV; Sublette, ME | 1 |
Artiges, E; Bellivier, F; Bruguière, P; Falissard, B; Galinowski, A; Gallarda, T; Leboyer, M; Lefaucheur, JP; Mangin, JF; Martinot, JL; Olié, JP; Paillère Martinot, ML; Picq, C; Ringuenet, D; Rivière, D; Willer, JC | 1 |
Eipper, F; Lee, L; Malone, K; Mann, JJ; Milak, MS; Olvet, DM; Oquendo, MA; Parsey, RV | 1 |
Bieling, PJ; Kennedy, SH; Konarski, JZ; Lau, MA; Mayberg, HS; McIntyre, RS; Segal, ZV | 2 |
Blair, JR; Drevets, WC; Hasler, G; Mondillo, K | 1 |
Haberkorn, U; Henn, FA; Kiening, KL; Kirsch, P; Meyer-Lindenberg, A; Sartorius, A; Unterberg, AW; von Gall, CC | 1 |
Baeken, C; Bossuyt, A; Clerinx, P; De Mey, J; De Raedt, R; Van Hove, C | 1 |
Bai, YM; Hirvonen, J; Hong, CJ; Hsieh, JC; Li, CT; Liou, YJ; Su, TP; Wang, SJ | 1 |
Fukuyama, H; Ishizu, K; Murai, T; Namiki, C; Oshita, A; Suga, H; Suwa, T; Takaya, S | 1 |
Tobe, E | 1 |
Campbell, C; Ellis, SP; Kegeles, LS; Keilp, JG; Malone, KM; Mann, JJ; Oquendo, M; Slifstein, M; Van Heertum, RL; Xanthopoulos, E | 1 |
Conca, A; König, P; Peschina, W; Prapotnik, M | 1 |
Bieling, P; Garson, C; Goldapple, K; Kennedy, S; Lau, M; Mayberg, H; Segal, Z | 1 |
Goldapple, K; Kennedy, S; Mayberg, HS; McIntosh, AR; Rafi-Tari, S; Segal, Z; Seminowicz, DA | 1 |
Buysse, DJ; Germain, A; Nofzinger, E; Wood, A | 1 |
Beuthien-Baumann, B; Füchtner, F; Herholz, K; Holthoff, VA; Koch, R; Lüdecke, S; Triemer, A; Winiecki, P; Zündorf, G | 1 |
Anderson, AD; Campbell, C; Mann, JJ; Milak, MS; Oquendo, MA; Parsey, RV | 1 |
Bauer, M; Heinz, A; Hommer, D; Kerich, M; Reimold, M; Williams, W | 1 |
Anderson, A; John Mann, J; Krunic, A; Malone, KM; Milak, M; Oquendo, MA; Parsey, RV; van Heertum, RL | 1 |
Keilp, J; Malone, KM; Mann, JJ; Milak, MS; Oquendo, MA; Parsey, RV | 1 |
Amanuma, M; Endo, K; Ida, I; Kumano, H; Matsuda, H; Mikuni, M; Oriuchi, N; Oshima, A; Takahashi, K; Yuuki, N | 1 |
Choo, IH; Jhoo, JH; Kang, EJ; Kang, WJ; Kim, KW; Lee, DS; Lee, DY; Lee, JS; Woo, JI; Youn, JC | 1 |
Cannon, DM; Carson, RE; Drevets, M; Drevets, WC; Eckelman, WC; Gandhi, S; Kiesewetter, DO; Nugent, AC; Rollis, D; Solorio, G; Williams, J | 1 |
Bonne, O; Charney, DS; Drevets, WC; Goldman, D; Herscovitch, P; Hu, XZ; Luckenbaugh, DA; Neumeister, A; Nugent, AC; Schwarz, M | 1 |
Beuthien-Baumann, B; Donix, M; Herholz, K; Herting, B; Holthoff, VA; Lampe, JB; Pöttrich, K; Reichmann, H; Triemer, A; von Kummer, R | 1 |
Artiges, E; Bragulat, V; Frouin, V; Martinot, JL; Paillère-Martinot, ML; Poline, JB | 1 |
Carballo, JJ; Cooper, TB; Malone, KM; Mann, JJ; Milak, MS; Oquendo, MA; Parsey, RV; Sher, L | 1 |
Aihara, M; Endo, K; Fukuda, M; Ida, I; Kumano, H; Matsuda, H; Mikuni, M; Oriuchi, N; Oshima, A; Takahashi, K; Yuuki, N | 1 |
Boles Ponto, LL; Brumm, MC; Johnson, HJ; Magnotta, V; McCormick, LM; Pierson, RK | 1 |
Abercrombie, HC; Benca, RM; Davidson, RJ; Holden, JE; Larson, CL; Lindgren, KA; Oakes, TR; Perlman, SB; Schaefer, SM; Ward, RT | 1 |
Kupfer, DJ; Meltzer, CC; Miewald, JM; Moore, RY; Nichols, TE; Nofzinger, EA; Price, J; Steppe, DA | 1 |
Alborzian, S; Baxter, LR; Brody, AL; Fairbanks, LA; Huang, SC; Maidment, K; Phelps, ME; Saxena, S; Silverman, DH; Wu, HM | 1 |
Clark, CC; Yatham, LN; Zis, AP | 1 |
Berman, S; Fasiczka, A; Meltzer, CC; Miewald, JM; Nofzinger, EA; Price, JC; Sembrat, RC; Thase, ME; Wood, A | 1 |
Alborzian, S; Au, SC; Baxter, LR; Brody, AL; Ho, MK; Ho, ML; Huang, SC; Maidment, KM; Saxena, S; Wu, HM | 1 |
Baxter, LR; Brody, AL; Fairbanks, LA; Ho, ML; Mandelkern, MA; Saxena, S | 1 |
Conca, A; Fritzsche, H; Hausmann, A; König, P; Peschina, W | 1 |
Alborzian, S; Baxter, LR; Brody, AL; Ho, MK; Ho, ML; Huang, SC; Maidment, KM; Saxena, S; Wu, HM; Zohrabi, N | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Depressive Disorder, Major
Article | Year |
---|---|
Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies.
Topics: Basal Ganglia; Blood Glucose; Cerebral Cortex; Depressive Disorder, Major; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Limbic System; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thalamus | 2014 |
Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies.
Topics: Adult; Blood Glucose; Depressive Disorder, Major; Electroencephalography; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Prosencephalon; Radiopharmaceuticals; Sleep, REM; Time Factors; Tomography, Emission-Computed; Wakefulness | 1999 |
13 trial(s) available for fluorodeoxyglucose f18 and Depressive Disorder, Major
Article | Year |
---|---|
Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls.
Topics: Adolescent; Adult; alpha-Methyltyrosine; Case-Control Studies; Catecholamines; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Symptom Assessment; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult | 2014 |
Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression.
Topics: Adult; Bipolar Disorder; Brain; Case-Control Studies; Caudate Nucleus; Depressive Disorder, Major; Female; Fenfluramine; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Putamen; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Suicide, Attempted; Young Adult | 2013 |
Pretreatment brain states identify likely nonresponse to standard treatments for depression.
Topics: Adult; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Male; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2014 |
The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Topics: Adult; Amygdala; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Glutamic Acid; Humans; Ketamine; Linear Models; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2016 |
Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET.
Topics: Adult; Bipolar Disorder; Brain; Cross-Over Studies; Depression; Depressive Disorder, Major; Dose-Response Relationship, Radiation; Double-Blind Method; Electric Stimulation Therapy; Electromagnetic Phenomena; Female; Fluorodeoxyglucose F18; Humans; Magnetoencephalography; Male; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Research Design; Severity of Illness Index; Treatment Outcome | 2009 |
Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
Topics: Adult; Antidepressive Agents; Brain Mapping; Combined Modality Therapy; Depressive Disorder, Major; Drug Resistance; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Transcranial Magnetic Stimulation; Treatment Outcome | 2010 |
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Positron-Emission Tomography; Venlafaxine Hydrochloride; Young Adult | 2009 |
Impairments of probabilistic response reversal and passive avoidance following catecholamine depletion.
Topics: Adolescent; Adult; alpha-Methyltyrosine; Avoidance Learning; Brain; Catecholamines; Conditioning, Operant; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Middle Aged; Positron-Emission Tomography; Reversal Learning; Reward; Stroop Test | 2009 |
Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders.
Topics: Adult; Affect; Bipolar Disorder; Blood Glucose; Brain Mapping; Depressive Disorder, Major; Energy Metabolism; Female; Fenfluramine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Prefrontal Cortex; Serotonin; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder.
Topics: Adult; Aggression; Borderline Personality Disorder; Brain Chemistry; Cerebral Cortex; Depressive Disorder, Major; Female; Fenfluramine; Fluorodeoxyglucose F18; Glucose; Hostility; Humans; Image Processing, Computer-Assisted; Impulsive Behavior; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2005 |
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.
Topics: Adult; Ambulatory Care; Amino Acids; Brain; Depressive Disorder, Major; Double-Blind Method; Female; Fluorodeoxyglucose F18; Genotype; Glucose; Humans; Male; Neural Pathways; Placebos; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prospective Studies; Psychiatric Status Rating Scales; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tissue Distribution; Tryptophan | 2006 |
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.
Topics: Adult; Brain; Cerebral Cortex; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Limbic System; Male; Middle Aged; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using.
Topics: Adult; Brain; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Limbic System; Male; Prefrontal Cortex; Radionuclide Imaging; Radiopharmaceuticals; Sleep, REM; Wakefulness | 2001 |
45 other study(ies) available for fluorodeoxyglucose f18 and Depressive Disorder, Major
Article | Year |
---|---|
Unintentional Weight Loss in Adults 65 Years or Older: A Symptom of Physical and Psychiatric Etiologies.
Topics: Aged; Anhedonia; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Humans; Malnutrition; Weight Loss | 2022 |
Brainstem glucose metabolism predicts reward dependence scores in treatment-resistant major depression.
Topics: Brain Stem; Character; Depression; Depressive Disorder, Major; Fluorodeoxyglucose F18; Glucose; Humans; Personality Inventory; Reward; Temperament | 2022 |
A PET imaging study of the brain changes of glucose metabolism in patients with temporal lobe epilepsy and depressive disorder.
Topics: Adult; Brain; Depressive Disorder, Major; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Temporal Lobe | 2021 |
Resting-state brain metabolic fingerprinting clusters (biomarkers) and predictive models for major depression in multiple myeloma patients.
Topics: Biomarkers; Brain; Brain Mapping; Case-Control Studies; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Middle Aged; Multiple Myeloma; Neuroimaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies | 2021 |
A case of recurrent depressive disorder presenting with Alice in Wonderland syndrome: psychopathology and pre- and post-treatment FDG-PET findings.
Topics: Alice in Wonderland Syndrome; Depressive Disorder, Major; Diagnosis, Differential; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Parietal Lobe; Positron Emission Tomography Computed Tomography | 2017 |
Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder.
Topics: Adult; Case-Control Studies; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Humans; Lupus Erythematosus, Systemic; Male; Positron-Emission Tomography; Prefrontal Cortex; Young Adult | 2017 |
Opposite subgenual cingulate cortical functional connectivity and metabolic activity patterns in refractory melancholic major depression.
Topics: Adult; Brain; Brain Mapping; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Temporal Lobe; Transcranial Magnetic Stimulation | 2020 |
Complete normalization of severe brain 18F-FDG hypometabolism following electroconvulsive therapy in a major depressive episode.
Topics: Aged; Brain; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2013 |
Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression.
Topics: Adult; Amygdala; Animals; Clozapine; Corticosterone; Depressive Disorder, Major; Designer Drugs; Enkephalins; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; GTP-Binding Protein alpha Subunits, Gi-Go; Heroin Dependence; Humans; Hungary; Limbic System; Male; Middle Aged; Neuroimaging; Neurons; Positron-Emission Tomography; Protein Precursors; Radiopharmaceuticals; Rats; Rats, Long-Evans; Recombinant Fusion Proteins; RNA, Messenger; United States | 2013 |
Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders.
Topics: Acoustic Stimulation; Adult; Affect; Amygdala; Bipolar Disorder; Depressive Disorder, Major; Emotions; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Hearing; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Rest; Task Performance and Analysis | 2014 |
Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Essential Tremor; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Lithium Compounds; Male; Memory Disorders; Memory, Episodic; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Primidone; Radiopharmaceuticals; Recurrence; Venlafaxine Hydrochloride | 2015 |
Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency?
Topics: Adult; Brain; Brain Mapping; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Transcranial Magnetic Stimulation; Treatment Outcome | 2017 |
[Correlation of region blood perfusion and glucose metabolism of the prefrontal lobes with clinical features in patients with first-episode depression].
Topics: Cerebrovascular Circulation; Depression; Depressive Disorder, Major; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Positron-Emission Tomography; Prefrontal Cortex; Spin Labels | 2015 |
Analysis of glucose metabolism of (18)F-FDG in major depression patients using PET imaging: Correlation of salivary cortisol and α-amylase.
Topics: alpha-Amylases; Biomarkers; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Hydrocortisone; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Saliva | 2016 |
Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary study.
Topics: Adult; Aged; Blood Glucose; Brain Mapping; Cerebral Cortex; Depressive Disorder, Major; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kidney Failure, Chronic; Male; Middle Aged; Neuropsychological Tests; Personality Assessment; Positron-Emission Tomography; Psychometrics; Reference Values; Renal Dialysis | 2008 |
Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression.
Topics: Adult; Cerebral Cortex; Depressive Disorder, Major; Fatty Acids, Unsaturated; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Positron-Emission Tomography | 2009 |
Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Mesencephalon; Middle Aged; Paroxetine; Positron-Emission Tomography; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient.
Topics: Deep Brain Stimulation; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Habenula; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Time Factors | 2010 |
HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging.
Topics: Adult; Antidepressive Agents; Brain; Depressive Disorder, Major; Drug Resistance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Transcranial Magnetic Stimulation; Treatment Outcome | 2009 |
Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism.
Topics: Adult; Antidepressive Agents; Blood Glucose; Brain; Combined Modality Therapy; Depressive Disorder, Major; Dominance, Cerebral; Drug Resistance; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Reference Values; Tomography, X-Ray Computed; Transcranial Magnetic Stimulation | 2010 |
Corticolimbic balance shift of regional glucose metabolism in depressed patients treated with ECT.
Topics: Adult; Antidepressive Agents; Brain; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
Progressive neuropsychiatric and brain abnormalities after smoke inhalation.
Topics: Activities of Daily Living; Brain; Cognition Disorders; Depressive Disorder, Major; DNA Damage; Fluorodeoxyglucose F18; Fructose; Humans; Male; Memory, Long-Term; Methylphenidate; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Sertraline; Smoke Inhalation Injury; Time Factors; Topiramate; Valproic Acid | 2012 |
Simultaneous pattern of rCBF and rCMRGlu in continuation ECT: case reports.
Topics: Adult; Basal Ganglia; Brain; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Fluorodeoxyglucose F18; Glucose; Hemodynamics; Humans; Oximes; Prefrontal Cortex; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed, Single-Photon | 2003 |
Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Blood Glucose; Brain Mapping; Cerebral Cortex; Cognitive Behavioral Therapy; Depressive Disorder, Major; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Limbic System; Male; Middle Aged; Nerve Net; Neural Pathways; Outcome and Process Assessment, Health Care; Paroxetine; Personality Inventory; Prefrontal Cortex; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Limbic-frontal circuitry in major depression: a path modeling metanalysis.
Topics: Algorithms; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Drug Resistance; Electroconvulsive Therapy; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Limbic System; Models, Neurological; Nerve Net; Paroxetine; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Functional neuroanatomical correlates of eye movements during rapid eye movement sleep in depressed patients.
Topics: Adult; Brain; Depressive Disorder, Major; Electroencephalography; Eye Movements; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Radiopharmaceuticals; Sleep, REM; Tomography, Emission-Computed | 2004 |
Changes in brain metabolism associated with remission in unipolar major depression.
Topics: Adolescent; Adult; Aged; Body Mass Index; Brain; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Severity of Illness Index; Weight Loss | 2004 |
Regional brain responses to serotonin in major depressive disorder.
Topics: Brain; Depressive Disorder, Major; Fenfluramine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Parietal Lobe; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin | 2004 |
Glucose utilization in the medial prefrontal cortex correlates with serotonin turnover rate and clinical depression in alcoholics.
Topics: Alcoholism; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Fluorodeoxyglucose F18; Glucose; Humans; Male; Pilot Projects; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Serotonin; Severity of Illness Index | 2004 |
Neuroanatomic correlates of psychopathologic components of major depressive disorder.
Topics: Adult; Basal Ganglia; Brain; Brain Mapping; Cerebral Cortex; Depressive Disorder, Major; Factor Analysis, Statistical; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Limbic System; Male; Neural Pathways; Positron-Emission Tomography; Psychiatric Status Rating Scales; Severity of Illness Index; Thalamus; Tissue Distribution | 2005 |
Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients--a preliminary PET study.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Blood Glucose; Brain; Cerebral Cortex; Depressive Disorder, Major; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasms; Nerve Net; Personality Inventory; Positron-Emission Tomography; Sensitivity and Specificity | 2007 |
Frontal dysfunction underlies depressive syndrome in Alzheimer disease: a FDG-PET study.
Topics: Aged; Alzheimer Disease; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.
Topics: Acetylcholine; Adult; Ambulatory Care; Bipolar Disorder; Brain; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyridines; Radioligand Assay; Receptor, Muscarinic M2; Synapses; Thiazoles; Tissue Distribution | 2006 |
Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes.
Topics: Aged; Brain Stem; Cerebellum; Cognition Disorders; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parietal Lobe; Parkinsonian Disorders; Pilot Projects; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index; Thalamus; Tomography, X-Ray Computed | 2007 |
Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis.
Topics: Adult; Affect; Biogenic Monoamines; Brain Stem; Caudate Nucleus; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluorodeoxyglucose F18; Fluoxetine; Gyrus Cinguli; Hippocampus; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Nucleus Accumbens; Positron-Emission Tomography; Psychomotor Disorders; Putamen; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2007 |
Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence.
Topics: Adult; Alcoholism; Brain; Brain Mapping; Depressive Disorder, Major; Female; Fenfluramine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2007 |
HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
Topics: Adult; Aged; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Dexamethasone; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Limbic System; Male; Middle Aged; Nerve Net; Pituitary-Adrenal System; Prefrontal Cortex; Radiopharmaceuticals | 2007 |
Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy.
Topics: Adult; Affect; Antidepressive Agents; Antipsychotic Agents; Brain; Brain Mapping; Combined Modality Therapy; Corpus Callosum; Depressive Disorder, Major; Dominance, Cerebral; Electroconvulsive Therapy; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Hippocampus; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Personality Inventory; Positron-Emission Tomography; Psychiatric Status Rating Scales; Treatment Outcome | 2007 |
Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patients.
Topics: Adult; Alpha Rhythm; Depressive Disorder, Major; Electrooculography; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Health Status; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Radiopharmaceuticals; Severity of Illness Index; Thalamus; Tomography, Emission-Computed | 1999 |
Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; Brain Mapping; Depressive Disorder, Major; Dose-Response Relationship, Drug; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Prognosis; Tomography, Emission-Computed; Treatment Outcome | 1999 |
A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression.
Topics: Adult; Animals; Blood Glucose; Brain; Brain Mapping; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Rats; Tomography, Emission-Computed | 2000 |
Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently.
Topics: Adult; Brain; Caudate Nucleus; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Radiopharmaceuticals; Thalamus; Tomography, Emission-Computed | 2001 |
Brain metabolic changes associated with symptom factor improvement in major depressive disorder.
Topics: Depressive Disorder, Major; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Paroxetine; Prefrontal Cortex; Psychomotor Disorders; Psychotherapy; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives. A brief report.
Topics: Adult; Brain; Case-Control Studies; Cerebrovascular Circulation; Depressive Disorder, Major; Drug Resistance; Electric Stimulation Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Transcranial Magnetic Stimulation; Treatment Outcome | 2002 |
Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.
Topics: Adult; Blood Glucose; Brain; Brain Mapping; Comorbidity; Depressive Disorder, Major; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Personality Inventory; Radiography; Tomography, Emission-Computed; Treatment Outcome | 2002 |